Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125394281 | 12539428 | 1 | I | 20160705 | 20160708 | 20160708 | PER | US-009507513-1607USA002688 | MERCK | 0.00 | F | Y | 0.00000 | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125394281 | 12539428 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | UNK | U | 12675 | TABLET | ||||||||
| 125394281 | 12539428 | 2 | C | KEYTRUDA | PEMBROLIZUMAB | 1 | Intravenous (not otherwise specified) | UNK, EVERY 3 WEEKS FOR 30 MIN | U | 0 | POWDER FOR INJECTION | Q3W | |||||||
| 125394281 | 12539428 | 3 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125394281 | 12539428 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125394281 | 12539428 | 1 | Stomatitis |
| 125394281 | 12539428 | 2 | Malignant melanoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125394281 | 12539428 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125394281 | 12539428 | 2 | 2015 | 0 |